KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ionis Pharmaceuticals (IONS) Non Operating Investment Income (2019 - 2026)

Ionis Pharmaceuticals (IONS) has disclosed Non Operating Investment Income for 15 consecutive years, with $22.6 million as the latest value for Q1 2026.

  • For Q1 2026, Non Operating Investment Income rose 1143.58% year-over-year to $22.6 million; the TTM value through Mar 2026 reached $35.0 million, up 573.42%, while the annual FY2025 figure was $10.2 million, 453.76% up from the prior year.
  • Non Operating Investment Income hit $22.6 million in Q1 2026 for Ionis Pharmaceuticals, up from $788000.0 in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $29.9 million in Q3 2025 and bottomed at -$18.3 million in Q2 2025.
  • Average Non Operating Investment Income over 5 years is $1.2 million, with a median of -$161000.0 recorded in 2023.
  • Year-over-year, Non Operating Investment Income crashed 1495.03% in 2024 and then soared 3302.5% in 2025.
  • Ionis Pharmaceuticals' Non Operating Investment Income stood at $3.3 million in 2022, then crashed by 104.9% to -$161000.0 in 2023, then plummeted by 1495.03% to -$2.6 million in 2024, then surged by 130.69% to $788000.0 in 2025, then soared by 2765.86% to $22.6 million in 2026.
  • According to Business Quant data, Non Operating Investment Income over the past three periods came in at $22.6 million, $788000.0, and $29.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.